ACCESSION: MSBNK-SMB_Measured-HSA001P0177001
RECORD_TITLE: Annotated; Cotinine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'19_posi_596': {'bp': 1568282.0, 'sum': 1810741.0}, '19_posi_656': {'bp': 1326612.0, 'sum': 1494459.0}, '17_posi_597': {'bp': 763571.0, 'sum': 884503.0}, '16_posi_637': {'bp': 761787.0, 'sum': 899233.0}, '5_posi_579': {'bp': 751879.0, 'sum': 915183.0}, '17_posi_660': {'bp': 570557.0, 'sum': 701636.0}, '8_posi_577': {'bp': 550200.0, 'sum': 678725.0}, '14_posi_648': {'bp': 386128.0, 'sum': 513210.0}, '12_posi_640': {'bp': 370515.0, 'sum': 469721.0}, '4_posi_642': {'bp': 361806.0, 'sum': 461371.0}, '8_posi_640': {'bp': 360516.0, 'sum': 473211.0}, '6_posi_644': {'bp': 310255.0, 'sum': 407833.0}, '18_posi_622': {'bp': 232006.0, 'sum': 317454.0}, '10_posi_617': {'bp': 207837.0, 'sum': 327688.0}, '3_posi_619': {'bp': 207286.0, 'sum': 298181.0}, '11_posi_622': {'bp': 206780.0, 'sum': 258570.0}, '7_posi_621': {'bp': 198072.0, 'sum': 280574.0}, '2_posi_623': {'bp': 196965.0, 'sum': 285549.0}, '13_posi_645': {'bp': 188072.0, 'sum': 269413.0}, '9_posi_606': {'bp': 188008.0, 'sum': 293517.0}, '1_posi_617': {'bp': 169234.0, 'sum': 249949.0}, '5_posi_666': {'bp': 167349.0, 'sum': 246819.0}, '15_posi_659': {'bp': 154489.0, 'sum': 252183.0}, '16_posi_705': {'bp': 103201.0, 'sum': 210348.0}}
COMMENT: RETENTION_TIME_STDEV 0.058
COMMENT: PRECURSOR_M/Z_RAW 177.101915
COMMENT: PRECURSOR_M/Z_STDEV 0.000043
COMMENT: PRECURSOR_IN_MS1 mz 177.102236; int 70.525; delta(ppm) 1.134876
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.017; C10H12N2O; [M+H]+; delta(ppm) -0.017036
COMMENT: PROPOSED_MF MS-FINDER 4.423; C10H12N2O; [M+H]+; delta(ppm) -0.019489
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.728; C10H12N2O; [M+H]+; delta(ppm) -0.019489
COMMENT: PROPOSED_MF SIRIUS5_Sirius 1.016; C7H13FN2O2; [M+H]+; delta(ppm) -6.471392
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.507; C8H17O2P; [M+H]+; delta(ppm) -9.346030
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.633; C9H17ClO; [M+H]+; delta(ppm) -119350.312723
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.922; C10H12N2O; [M+H]+; delta(ppm) -0.019489
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.070; C7H13FN2O2; [M+H]+; delta(ppm) -6.471392
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.004; C8H17O2P; [M+H]+; delta(ppm) -9.346030
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.004; C9H17ClO; [M+H]+; delta(ppm) -119350.312723
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.117; C10H12N2O; [M+H]+; delta(ppm) -0.019489
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.406; C7H13FN2O2; [M+H]+; delta(ppm) -6.471392
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.850; C5H11FN5O; [M+H]+; delta(ppm) 1.109858
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.507; C8H17O2P; [M+H]+; delta(ppm) -9.346030
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.633; C9H17ClO; [M+H]+; delta(ppm) -119350.312723
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.192; C8H10N5; [M+H]+; delta(ppm) 7.561860
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.164; C7H15ClN3; [M+H]+; delta(ppm) -119344.433060
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.750; C6H15N3OP; [M+H]+; delta(ppm) -1.764823
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.578; C4H13N6P; [M+H]+; delta(ppm) 5.816499
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.948; C10H12N2O; [M+H]+; delta(ppm) -0.019489
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.052; C7H13FN2O2; [M+H]+; delta(ppm) -6.471392
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 18.000; UIKROCXWUNQSPJ-VIFPVBQESA-N; C10H12N2O; Massbank:EQ328202 Cotinine(5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 10.000; UIKROCXWUNQSPJ-UHFFFAOYSA-N; C10H12N2O; Massbank:BML00569 Cotinine
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; QZAYGJVTTNCVMB-UHFFFAOYSA-N; C10H12N2O; ReSpect:PT100340 Serotonin hydrochloride5-HT5-Hydoxytryptamine hydrochloride3-(2-Aminoethyl)-5-hydroxyindole hydrochlorideEnteramine3-(2-aminoethyl)-1H-indol-5-ol
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.865; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; COC1=CC=CC2=C1C(CN)=CN2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.834; CXOGMMQKRNROKJ-UHFFFAOYSA-N; [M+H]+; O=C1C=CC=C2N1CC3CNCC23
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.800; RSNDUSNTDLGWQM-UHFFFAOYSA-N; [M+H]+; OC=1C=CC=2N=C(N(C2C1)CC)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.797; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; CN(C)C=CC(=O)C1=CN=CC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.758; UIKROCXWUNQSPJ-UHFFFAOYNA-N; [M+H]+; CN1C(CCC1=O)C1=CN=CC=C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.265; SNIXRMIHFOIVBB-UHFFFAOYSA-N; [M+H]+; N-hydroxy tryptamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.212; UIKROCXWUNQSPJ-UHFFFAOYNA-N; [M+H]+; Cotinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.153; QZAYGJVTTNCVMB-UHFFFAOYSA-N; [M+H]+; Serotonin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.473; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; 4-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.458; WNWJSYYPDDQIQV-UEQNJFAPNA-N; [M+H]+; (1S)-1-amino-2-(1H-indol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.448; GQLSEYOOXBRDFZ-UEQNJFAPNA-N; [M+H]+; UNPD113047
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.424; WZTKTNRVJAMKAS-UHFFFAOYSA-N; [M+H]+; UNPD48906
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.412; GAHLHXRCZDVQSW-UHFFFAOYSA-N; [M+H]+; 1-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.406; CXOGMMQKRNROKJ-UHFFFAOYSA-N; [M+H]+; Cyfusine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.406; RSEAKKXLVFFQGA-UHFFFAOYSA-N; [M+H]+; 5,6-diethyl-[1,3]oxazolo[5,4-b]pyridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.395; CPWSAKUPXWXJPQ-MDOHGIEYNA-N; [M+H]+; UNPD61396
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.384; NUJFYQDHTBBYKQ-JLDDOWRYNA-N; [M+H]+; UNPD92821
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.360; RSNDUSNTDLGWQM-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methyl-1H-1,3-benzodiazol-6-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.343; YJXZYKIERAACAC-UHFFFAOYSA-N; [M+H]+; 4-(hydroxyimino)-3,6,6-trimethylbicyclo[3.1.0]hex-2-ene-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.332; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; 2-Propen-1-one, 3-(dimethylamino)-1-(3-pyridinyl)-
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.327; OFCNTYBPPAQCRE-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-3H-indol-5-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.320; LJQBMYDFWFGESC-UHFFFAOYSA-N; [M+H]+; 4-Methylaminorex
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; BWVQIBKUGHYXLO-UHFFFAOYSA-N; [M+H]+; 1-(3-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; BXJMRXBQNLKDCI-UHFFFAOYSA-N; [M+H]+; 2,2-Dimethyl-1,2-Dihydroquinazolin-4(3H)-One
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; CLUOVKPXNPEBBU-UHFFFAOYSA-N; [M+H]+; N'-phenylbut-2-enehydrazide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; ILNUQOOAYAAWSD-UHFFFAOYSA-N; [M+H]+; 1-methyl-2(h)-quinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; SVJPLZNMCJQWPJ-UHFFFAOYSA-N; [M+H]+; 1-(4-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; SZDFIVJGWVHZAV-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; VQAMXXXBDNKODW-UHFFFAOYSA-N; [M+H]+; 1-(2-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.268; YDWIHMVUUGVOLZ-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-indol-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.777; UUSVBSIMANJSGD-UHFFFAOYSA-N; [M+H]+; 9-hydroxy-2,4-dimethyl-octahydro-2H-1??-pyrido[1,2-a]pyrimidin-5-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UIKROCXWUNQSPJ-UHFFFAOYNA-N; [M+H]+; Cotinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; 2-Propen-1-one, 3-(dimethylamino)-1-(3-pyridinyl)-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GQLSEYOOXBRDFZ-UEQNJFAPNA-N; [M+H]+; UNPD113047
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.619; YJXZYKIERAACAC-UHFFFAOYSA-N; [M+H]+; 4-(hydroxyimino)-3,6,6-trimethylbicyclo[3.1.0]hex-2-ene-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.592; UUSVBSIMANJSGD-UHFFFAOYSA-N; [M+H]+; 9-hydroxy-2,4-dimethyl-octahydro-2H-1??-pyrido[1,2-a]pyrimidin-5-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.577; ILNUQOOAYAAWSD-UHFFFAOYSA-N; [M+H]+; 1-methyl-2(h)-quinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.533; CXOGMMQKRNROKJ-UHFFFAOYSA-N; [M+H]+; Cyfusine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.529; BXJMRXBQNLKDCI-UHFFFAOYSA-N; [M+H]+; 2,2-Dimethyl-1,2-Dihydroquinazolin-4(3H)-One
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.525; NUJFYQDHTBBYKQ-JLDDOWRYNA-N; [M+H]+; UNPD92821
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.515; CPWSAKUPXWXJPQ-MDOHGIEYNA-N; [M+H]+; UNPD61396
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.499; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; 4-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.498; RSEAKKXLVFFQGA-UHFFFAOYSA-N; [M+H]+; 5,6-diethyl-[1,3]oxazolo[5,4-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.496; SNIXRMIHFOIVBB-UHFFFAOYSA-N; [M+H]+; N-hydroxy tryptamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.496; WNWJSYYPDDQIQV-UEQNJFAPNA-N; [M+H]+; (1S)-1-amino-2-(1H-indol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.485; RSNDUSNTDLGWQM-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methyl-1H-1,3-benzodiazol-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.480; BWVQIBKUGHYXLO-UHFFFAOYSA-N; [M+H]+; 1-(3-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.480; SVJPLZNMCJQWPJ-UHFFFAOYSA-N; [M+H]+; 1-(4-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.480; VQAMXXXBDNKODW-UHFFFAOYSA-N; [M+H]+; 1-(2-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.479; GAHLHXRCZDVQSW-UHFFFAOYSA-N; [M+H]+; 1-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.479; SZDFIVJGWVHZAV-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.473; LJQBMYDFWFGESC-UHFFFAOYSA-N; [M+H]+; 4-Methylaminorex
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.459; QZAYGJVTTNCVMB-UHFFFAOYSA-N; [M+H]+; Serotonin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.459; WZTKTNRVJAMKAS-UHFFFAOYSA-N; [M+H]+; UNPD48906
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.281; CLUOVKPXNPEBBU-UHFFFAOYSA-N; [M+H]+; N'-phenylbut-2-enehydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.281; YDWIHMVUUGVOLZ-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-indol-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.258; OFCNTYBPPAQCRE-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-3H-indol-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.323; QZAYGJVTTNCVMB-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indol-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.062; UIKROCXWUNQSPJ-VIFPVBQESA-N; [M+H]+; (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; MAXMUBIIZUKOJF-UHFFFAOYSA-N; [M+H]+; 1-pyridin-4-ylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; CSNJUQMJDHNKHI-UHFFFAOYSA-N; [M+H]+; 1-pyridin-2-ylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; 3-(dimethylamino)-1-pyridin-3-ylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; BWERGHWJEBQNQV-SOFGYWHQSA-N; [M+H]+; (E)-3-(dimethylamino)-1-pyridin-2-ylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; JZGHSXBVKSMAKH-VMPITWQZSA-N; [M+H]+; (E)-3-(dimethylamino)-1-pyridin-4-ylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; ZANPCQHDEUORJP-UHFFFAOYSA-N; [M+H]+; 4,4-dimethyl-2-pyridin-2-yl-5H-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; KYLMCPQKMNYJGT-UHFFFAOYSA-N; [M+H]+; 3,3-dimethyl-4-pyridin-4-ylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; GQLSEYOOXBRDFZ-UHFFFAOYSA-N; [M+H]+; 2-pyridin-3-ylpyrrolidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; GGPHOOFWHDUFIG-XYOKQWHBSA-N; [M+H]+; (E)-N-but-3-en-2-yloxy-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; NXPTYENGRYHQBC-KPKJPENVSA-N; [M+H]+; (E)-N-(2-methylprop-2-enoxy)-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; RIKQERCQCNJIIU-UHFFFAOYSA-N; [M+H]+; 6-pyridin-2-ylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; LJQBMYDFWFGESC-UHFFFAOYSA-N; [M+H]+; 4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; SNIXRMIHFOIVBB-UHFFFAOYSA-N; [M+H]+; N-[2-(1H-indol-3-yl)ethyl]hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; FKIRTWDHOWAQGX-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.769; TZPIKGCQLFRHGR-UHFFFAOYSA-N; [M+H]+; 4-amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.723; BBPWQLMHOSRDMA-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,2,3,5-tetrahydro-1,5-benzodiazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; CWVWILIKKMHQDN-XYOKQWHBSA-N; [M+H]+; (E)-1-(3-methylpyridin-4-yl)-N-prop-2-enoxymethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; MQMWEVBWFGVBBL-DHZHZOJOSA-N; [M+H]+; (E)-1-(6-methylpyridin-2-yl)-N-prop-2-enoxymethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.700; ZZEYCGJAYIHIAZ-UHFFFAOYSA-N; [M+H]+; 4-methyl-1-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.700; PLQUEAJMHWMBTG-UHFFFAOYSA-N; [M+H]+; 2-(2-methyl-4,5,6,7-tetrahydro-1,3-benzoxazol-4-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; PRGOOZYYBRKHKN-UHFFFAOYSA-N; [M+H]+; 2-butan-2-yloxypyridine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; MRKGWHOKZRAFEQ-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxy]pyridine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.696; JZMHFZCLNHTHSO-UHFFFAOYSA-N; [M+H]+; 2-[3-(cyanomethyl)-7-oxabicyclo[2.2.1]heptan-2-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.695; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; (4-methoxy-1H-indol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.686; CLKQZOVQZNETMH-UHFFFAOYSA-N; [M+H]+; 3-amino-1-phenylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.686; UDKJUMSGHZGQEH-UHFFFAOYSA-N; [M+H]+; 4-amino-1-phenylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.682; CQFSGSFSOWEIGO-UHFFFAOYSA-N; [M+H]+; 3-(1H-benzimidazol-2-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.681; HXNWGBPRRHESCL-UHFFFAOYSA-N; [M+H]+; 1-(1-methylbenzimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.676; YNFLIDHXMNKSQR-UHFFFAOYSA-N; [M+H]+; 3-propyl-1H-benzimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.676; SZDFIVJGWVHZAV-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1,3-dihydroindol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.660; IOMOVAPYJQVJDK-UHFFFAOYSA-N; [M+H]+; 1-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.658; ZQGGRBIDRBYUJS-UHFFFAOYSA-N; [M+H]+; 1-(3-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; YGCVNEQVUUMKJL-UHFFFAOYSA-N; [M+H]+; 2-amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; XTQFXSVIFJUEAP-UHFFFAOYSA-N; [M+H]+; 3-amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; RHINWRKJVGGOJR-UHFFFAOYSA-N; [M+H]+; 2-amino-N-prop-2-enylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; CAPDPGRIQUJAGR-UHFFFAOYSA-N; [M+H]+; N-(3-aminophenyl)cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; JXFJQPDXISQZHE-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-isoindol-5-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; OFWIPSFSNBNOQC-UHFFFAOYSA-N; [M+H]+; 1-(2-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; AHNRHYLMLVGCOC-UHFFFAOYSA-N; [M+H]+; 5-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; LAULYXTUHMXWOU-UHFFFAOYSA-N; [M+H]+; 5-(3-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; KHWGWQQVNONIPZ-UHFFFAOYSA-N; [M+H]+; 4-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; YCURMYBAXCTAFM-UHFFFAOYSA-N; [M+H]+; 4-(3-aminophenoxy)butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; MJPWQUIXUPCRAW-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-indol-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; HRFUMFZRYZHYEJ-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; AVLYOUOURMHIHZ-UHFFFAOYSA-N; [M+H]+; 2-[4-(2-aminoethoxy)phenyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.655; XCHVJJNMJKSGNU-UHFFFAOYSA-N; [M+H]+; 4-ethynyl-1-(oxolan-3-ylmethyl)pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.626; MOBYIROICQZPDG-UHFFFAOYSA-N; [M+H]+; 4-amino-3-propan-2-yloxybenzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.622; SOTNTWXGJKWKIM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1-methyl-3H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.619; VGOSHSFVBSXTOZ-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.619; ATJDZCZAGYKBTH-UHFFFAOYSA-N; [M+H]+; 7-(aminomethyl)-3,4-dihydro-2H-isoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.619; RFAJSRJOKXNYCH-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-2-methyl-3H-isoindol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.614; LOZKZWIQDVEDCQ-UHFFFAOYSA-N; [M+H]+; 1-(6-amino-2,3-dihydroindol-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.613; WSDUFDGEYKOQRT-UHFFFAOYSA-N; [M+H]+; 1-(5-amino-2,3-dihydroindol-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.613; IWARVYFPBLDOAK-UHFFFAOYSA-N; [M+H]+; 6-amino-3,3-dimethyl-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.613; ULWJTPAOSJSHFG-UHFFFAOYSA-N; [M+H]+; 6-amino-1-methyl-3,4-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; OFBPSKIFXNJCAG-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; RDKNTOVJVFYGPA-UHFFFAOYSA-N; [M+H]+; 3,3-dimethyl-1,4-dihydroquinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; XRJMPABWIZHNQA-UHFFFAOYSA-N; [M+H]+; 8-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; QYJOWWRUCCAUHW-UHFFFAOYSA-N; [M+H]+; 5-amino-3,3-dimethyl-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; QEZZUFANNFFZIH-UHFFFAOYSA-N; [M+H]+; 7-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; ZFSYJCQFOKJSFE-UHFFFAOYSA-N; [M+H]+; 1-(7-amino-2,3-dihydroindol-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; PYVVLSILSIVNQC-UHFFFAOYSA-N; [M+H]+; 5-amino-1-ethyl-3H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; IWHJGOLLYAXMLD-UHFFFAOYSA-N; [M+H]+; 5-methyl-2,3-dihydro-1H-1,5-benzodiazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; NSAVOLZYPAFSLW-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,2,3,5-tetrahydro-1,5-benzodiazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; RXAVXDBLOBNIFT-UHFFFAOYSA-N; [M+H]+; 4,4-dimethyl-3,1-benzoxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; BAUHDHWVXAOSEF-VIFPVBQESA-N; [M+H]+; (2S)-N-methyl-2,3-dihydro-1H-indole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.608; SJJLNXJJMNKZKF-UHFFFAOYSA-N; [M+H]+; 3-(3-methoxyanilino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.608; YIOYWZUOBVMFGA-UHFFFAOYSA-N; [M+H]+; 1-(5-amino-1,3-dihydroisoindol-2-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.608; PSDSAEYHBZOZBR-UHFFFAOYSA-N; [M+H]+; 6-amino-2-ethyl-3H-isoindol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.607; JFMNKDRNEZZRBW-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.605; LRIVVMZEHDTDGA-UHFFFAOYSA-N; [M+H]+; 7-amino-2-methyl-3,4-dihydroisoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.605; GTNSBFKKRPRPKU-UHFFFAOYSA-N; [M+H]+; 8-amino-2,3,4,5-tetrahydro-2-benzazepin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.605; FWPPPTIFLPLVOD-UHFFFAOYSA-N; [M+H]+; 6-amino-2-methyl-3,4-dihydroisoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.605; KZGROFOZYOFEFZ-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-3,4-dihydroisoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.604; YZYJYCPYUXPNPE-UHFFFAOYSA-N; [M+H]+; 3-amino-1-methyl-3,4-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.604; SBBGNRXYCGCZGA-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,3,4,5-tetrahydro-1,4-benzodiazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.599; YATNLYZMTPNWHI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1,4-dihydroisoquinolin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.598; GQRGMRVSJVMBMH-UHFFFAOYSA-N; [M+H]+; 6-tert-butyl-2-oxo-1H-pyridine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.598; JQKHEKMMKSMRTE-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-7,8-dihydro-6H-quinolin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.595; YLPNAIOOSLKUHD-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline-6-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.591; XJSKJJZBZSWZGV-UHFFFAOYSA-N; [M+H]+; 5-amino-2-propan-2-yloxybenzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.586; DPCGMMLZFLMVGJ-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline-7-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.585; FIARATPVIIDWJT-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.581; MLSKUXJIZZNRSU-UHFFFAOYSA-N; [M+H]+; 1-phenyl-3-prop-2-enylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.581; FDRHNNNJJNRFLO-UHFFFAOYSA-N; [M+H]+; 1-(2-methyl-1,3-benzoxazol-6-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.581; ZJMZHOMUFKQBLT-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-3,4-dihydro-1H-quinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.577; SWXSODIZVQALAJ-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.576; DBCGDMLNSRGMLI-UHFFFAOYSA-N; [M+H]+; N-benzyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.575; UMDWJYHTZUWTET-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1H-indol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.574; JNZGAKJBZUGXCU-UHFFFAOYSA-N; [M+H]+; 1-methyl-5-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; XCWLYFPMRHWWAG-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)-2-methyl-3H-isoindol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.570; VJWNLHRQOCVMNI-UHFFFAOYSA-N; [M+H]+; 2-propoxy-1H-benzimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.570; CURPBJGJXFWNMF-UHFFFAOYSA-N; [M+H]+; 2-(2-methylbenzimidazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.570; SCNIZJJJBSCYAV-UHFFFAOYSA-N; [M+H]+; 2-(1-methoxyethyl)-1H-benzimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.570; PMZZBUJEPJUANN-UHFFFAOYSA-N; [M+H]+; 1-(6-methyl-1H-benzimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.570; WFRDNWDYUJHLHA-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yl-1,3-benzoxazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.570; GRQAHHVRIFRTRC-UHFFFAOYSA-N; [M+H]+; 2-(1H-benzimidazol-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -7.626; UIKROCXWUNQSPJ; [M+H]+; Cotinina
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.998; GQLSEYOOXBRDFZ; [M+H]+; N-Formylnornicotine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.650; DOHZNHZHDHMXQB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.758; IOMOVAPYJQVJDK; [M+H]+; (4-Aminophenyl)pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.216; ZQGGRBIDRBYUJS; [M+H]+; Oprea1_818804
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.250; WHAUNCLSZCNCTE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.061; JNZGAKJBZUGXCU; [M+H]+; 1-Methyl-5-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.511; SNIXRMIHFOIVBB; [M+H]+; N-hydroxyl-tryptamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.072; OFWIPSFSNBNOQC; [M+H]+; 1-(2-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.587; GGPHOOFWHDUFIG; [M+H]+; N-but-3-en-2-yloxy-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.101; SZDFIVJGWVHZAV; [M+H]+; 3-(2-aminoethyl)indolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.540; SSEYDGGXERWOIC; [M+H]+; Acetone benzoylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.482; TZPIKGCQLFRHGR; [M+H]+; 4-Amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.710; ZJMZHOMUFKQBLT; [M+H]+; 4-(aminomethyl)-1,2,3,4-tetrahydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.118; GAVZUXBKQVMADB; [M+H]+; 1-cyclopropyl-3-phenylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.643; ULWJTPAOSJSHFG; [M+H]+; 6-amino-1-methyl-3,4-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.519; XRJMPABWIZHNQA; [M+H]+; 8-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.968; CAPDPGRIQUJAGR; [M+H]+; N-(3-aminophenyl)cyclopropylcarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -313.992; MZLRFUCMBQWLNV; [M+H]+; dimethylaminopyridinylpropenone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.094; NXPTYENGRYHQBC; [M+H]+; N-(2-methylprop-2-enoxy)-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.671; LVPLGMIOSVEITG; [M+H]+; Oprea1_270461
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.317; LWGKCPAYDQWMMS; [M+H]+; 6-Hydroxy-N-methyl Myosmine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -325.050; QZAYGJVTTNCVMB; [M+H]+; Antemoqua
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -325.911; GAHLHXRCZDVQSW; [M+H]+; 1H-Indole-3-methanamine, 1-methoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.692; MLSKUXJIZZNRSU; [M+H]+; N-allyl-N''-phenylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -327.738; VQAMXXXBDNKODW; [M+H]+; Oprea1_493326
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -328.472; YKDYCKHEKOEVJM; [M+H]+; 4-Methoxyindole-3-methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -328.997; HUHADASXDUCZMY; [M+H]+; 3-(Phenylhydrazono)-2-butanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.262; DKWUEAZDXGFDFD; [M+H]+; N-(dimethylaminomethylidene)benzamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.577; CQFSGSFSOWEIGO; [M+H]+; zlchem 37
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.930; WZTKTNRVJAMKAS; [M+H]+; 6-Hydroxytryptamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.394; BWVQIBKUGHYXLO; [M+H]+; 3-Pyrazolidinone, 1-(3-methylphenyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.510; FKIRTWDHOWAQGX; [M+H]+; 3-(2-aminoethyl)-1H-indol-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -334.022; SVJPLZNMCJQWPJ; [M+H]+; Oprea1_250793
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.222; WNWJSYYPDDQIQV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.469; FFFAXGTZBUMKTI; [M+H]+; 6-(pyrrolidin-1-yl)nicotinaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.105; MOBYIROICQZPDG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.757; CLUOVKPXNPEBBU; [M+H]+; N''-phenylbut-2-enehydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.119; XHYBFCBDMIPDON; [M+H]+; 1-phenyldiazinan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.231; HXNWGBPRRHESCL; [M+H]+; 2-Benzimidazolemethanol,1-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.724; XVTZMKHBKGYOKU; [M+H]+; 3-(1,4,5,6-tetrahydropyrimidin-2-yl)phenol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -342.876; ASEAXFLYJBVEGB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.269; BBPWQLMHOSRDMA; [M+H]+; Oprea1_799819
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -344.453; CPWSAKUPXWXJPQ; [M+H]+; (7R)-7-methyl-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.870; GPSGRRNYZJYVQT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.541; MQMWEVBWFGVBBL; [M+H]+; 1-(6-methylpyridin-2-yl)-N-prop-2-enoxymethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.548; OEGCCJDCPVXFLC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.365; UGMMLOHVKZGOJU; [M+H]+; ACMC-20crwz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -363.103; OTXOLASULYVVKB; [M+H]+; N''-(4-methylbenzylidene)acetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -368.558; CVQPWOAQBMGTLS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -369.231; FDRHNNNJJNRFLO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.026; RDKNTOVJVFYGPA; [M+H]+; Oprea1_274771
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.200; FIARATPVIIDWJT; [M+H]+; 5-methyl-1-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.284; BWERGHWJEBQNQV; [M+H]+; ACMC-20aniv
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -377.487; RSNDUSNTDLGWQM; [M+H]+; 3-ethyl-2-methylbenzimidazol-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -378.181; NUJFYQDHTBBYKQ; [M+H]+; 1,5-dimethyl-2,4-dihydro-1H-2,7-naphthyridin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.242; OIGIQMJAAZXDQH; [M+H]+; 1,4,5,6-Tetrahydro-5-phenoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.595; PGTOGOCRLGQJNM; [M+H]+; 1-(3-methylphenyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -386.077; KIQXCFBLXGRXPY; [M+H]+; 2-(Fluoromethyl)dehydroornithine methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -386.302; GQRGMRVSJVMBMH; [M+H]+; 6-(tert-Butyl)-2-hydroxynicotinonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -387.070; LOZKZWIQDVEDCQ; [M+H]+; Oprea1_552062
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.117; WSDUFDGEYKOQRT; [M+H]+; Oprea1_842763
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -389.609; NLTYZPBQHXXZGL; [M+H]+; (5,6-dimethylbenzimidazol-2-yl)methan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -390.998; BGKOOWIPOZKILG; [M+H]+; alpha-Hydroxymethyltolazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -391.193; VJWNLHRQOCVMNI; [M+H]+; 2-Propoxybenzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -392.147; RSEAKKXLVFFQGA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -392.314; YDWIHMVUUGVOLZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -393.356; TXONMTHZPYUUSK; [M+H]+; 1-(2-imidazolin-2-yl)-2-methoxybenzene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -394.109; ZFSYJCQFOKJSFE; [M+H]+; Oprea1_302168
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -394.674; QLOGFFCTOGPFIU; [M+H]+; 2-(o-Toluidino)-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -398.355; BXJMRXBQNLKDCI; [M+H]+; Oprea1_263737
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -404.473; LPMXHTSWSHVNSG; [M+H]+; 2-(methylamino)-1,4-dihydroisoquinolin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -406.246; MKENSKQNBRWBOI; [M+H]+; 2-(m-Toluidino)-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -406.744; DBCGDMLNSRGMLI; [M+H]+; 2-Benzylamino-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -410.145; PFCNDSQZKWGKTN; [M+H]+; (5,6-dimethylbenzimidazol-1-yl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -412.621; YWUNGYFXNDOGNZ; [M+H]+; Piperazinone, 1-phenyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -414.992; LJQBMYDFWFGESC; [M+H]+; 4-Methylaminorex
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.046; ZZEYCGJAYIHIAZ; [M+H]+; Phenidone B
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -428.031; PINRUEQFGKWBTO; [M+H]+; 2-Imino-3-methyl-5-phenyloxazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -438.530; YIOYWZUOBVMFGA; [M+H]+; 1-(5-amino-1,3-dihydroisoindol-2-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -440.152; PMBQYJGSKZZJKC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -440.398; CXOGMMQKRNROKJ; [M+H]+; 1,2,3,3a,4,9b-hexahydropyrrolo[3,4-a]indolizin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -441.779; JZMHFZCLNHTHSO; [M+H]+; 7-Oxabicyclo(2.2.1)heptane-2,3-diacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -450.773; YJXZYKIERAACAC; [M+H]+; Ambcb5621190
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -478.506; RXAVXDBLOBNIFT; [M+H]+; 4,4-dimethyl-3,1-benzoxazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.971; UIKROCXWUNQSPJ; [M+H]+; Cotinina
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -44.444; UIKROCXWUNQSPJ; [M+H]+; Cotinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.324; GQLSEYOOXBRDFZ; [M+H]+; 2-(pyridin-3-yl)pyrrolidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -196.985; LWGKCPAYDQWMMS; [M+H]+; 6-Hydroxy-N-Methylmyosmine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -198.148; NXPTYENGRYHQBC; [M+H]+; 4-Pyridinecarboxaldehyde, O-(2-methyl-2-propenyl)oxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.146; DOHZNHZHDHMXQB; [M+H]+; 1-Methyl-5-pyridin-3-ylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -208.248; GGPHOOFWHDUFIG; [M+H]+; 4-Pyridinecarboxaldehyde, O-(1-methyl-2-propenyl)oxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.267; KYLMCPQKMNYJGT; [M+H]+; 3,3-Dimethyl-4-(pyridin-4-yl)azetidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.007; AHNRHYLMLVGCOC; [M+H]+; (5S)-5-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.694; WHAUNCLSZCNCTE; [M+H]+; (3E)-4-(methylamino)-1-(pyridin-3-yl)but-3-en-1-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.149; KIQXCFBLXGRXPY; [M+H]+; 3-Pentenoic acid, 2,5-diamino-2-(fluoromethyl)-, methyl ester, (E)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.959; UIKROCXWUNQSPJ; [M+H]+; Cotinine
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Cotinine, UIKROCXWUNQSPJ-VIFPVBQESA-N; Matching to 18 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0001046;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H12N2O
CH$EXACT_MASS: 176.094963
CH$SMILES: CN1[C@@H](CCC1=O)C2=CN=CC=C2
CH$IUPAC: InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3/t9-/m0/s1
CH$NAME: Cotinine
CH$NAME: Cotinine
CH$NAME: (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
CH$LINK: INCHIKEY UIKROCXWUNQSPJ-VIFPVBQESA-N
CH$LINK: PUBCHEM CID:854019
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.271
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 177.102236
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-0900000000-a174b01b8b30ae8daae6
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  80.0493373 43.9787 80.049874 1.6365 6.54 0.9654 23 f{C5H6N1}/-1.73ppm,p-C5H7N1O1
  89.0595409 29.8043 89.059967 1.3923 23.00 -0.2033 18 ?
  97.0758474 16.5144 97.076192 1.9160 9.84 0.3873 17 f{C5H9N2}/-1.83ppm,p-C5H4O1
  98.0599121 22.1388 98.060249 1.7846 4.31 0.9158 19 f{C5H8N1O1}/-1.31ppm,p-C5H5N1
  136.0213827 30.6784 136.021290 2.1394 18.83 0.0682 23 ?
  149.0231686 48.3631 149.023067 1.9930 28.11 0.0661 24 ?
  177.0775113 99.7383 177.077392 5.7263 76.78 -0.1593 17 ?
  177.1019162 999.0000 177.101797 1.2083 0.00 1.0000 24 f{C10H13N2O1}/-1.83ppm,p
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  80.049337 43.98 43
  89.059541 29.80 29
  97.075847 16.51 16
  98.059912 22.14 22
  136.021383 30.68 30
  149.023169 48.36 48
  177.077511 99.74 99
  177.101916 999.00 999
//
